4d Molecular Therapeutics In shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $53k | 4.9k | 10.81 |
| 2024-06-30 | $103k | 4.9k | 20.99 |
| 2024-03-31 | $125k | 3.9k | 31.86 |
| 2023-12-31 | $80k | 3.9k | 20.26 |
| 2023-09-30 | $50k | 3.9k | 12.73 |
| 2023-06-30 | $47k | 2.6k | 18.07 |
| 2023-03-31 | $37k | 2.2k | 17.19 |
| 2022-12-31 | $43k | 2.2k | 19.84 |
| 2022-09-30 | $17k | 2.2k | 7.87 |
| 2022-06-30 | $15k | 2.2k | 6.95 |
| 2022-03-31 | $33k | 2.2k | 15.28 |
| 2021-12-31 | $47k | 2.2k | 21.77 |
| 2021-09-30 | $43k | 1.6k | 26.77 |
| 2021-06-30 | $15k | 633 | 23.70 |
| 2021-03-31 | $27k | 633 | 42.65 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors